Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neuroscience Methods

• Publication date

  2005-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JNEUMETH.2004.09.015PMID 15763140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [3H] sertraline binding to rat brain membranes

  2005cited by this paper
• Na+ and the substrate permeation pathway in dopamine transporters.

  2003cited by this paper
• Dopamine transporter as target for drug development of cocaine dependence medications.

  2003cited by this paper
• Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?

  2002cited by this paper
• Probes for the dopamine transporter: New leads toward a cocaine‐abuse therapeutic—A focus on analogues of benztropine and rimcazole

  2002cited by this paper
• The Uptake Inhibitors Cocaine and Benztropine Differentially Alter the Conformation of the Human Dopamine Transporter*

  2001cited by this paper
• Regulation of the human norepinephrine transporter by cocaine and amphetamine.

  2000cited by this paper
• IIIIIIInteraction of Na+, K+, and Cl‐ with the Binding of Amphetamine, Octopamine, and Tyramine to the Human Dopamine Transporter

  2000cited by this paper
• RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, as a tool for irreversibly inactivating dopamine transporter function in vitro

  2000cited by this paper
• Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatraline.

  2000cited by this paper
• Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine 1

  2000cited by this paper
• Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

  1999cited by this paper
• Studies of selected phenyltropanes at monoamine transporters.

  1999cited by this paper
• Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.

  1998cited by this paper
• Role of Axonal and Somatodendritic Monoamine Transporters in Action of Uptake Blockers

  1997cited by this paper
• Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.

  1997cited by this paper
• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  1997cited by this paper
• Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.

  1996cited by this paper
• Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter

  1996cited by this paper
• Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters.

  1996cited by this paper
• Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs.

  1996cited by this paper
• [3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments.

  1996cited by this paper
• Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.

  1995cited by this paper
• Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter.

  1995cited by this paper
• Comparison of (R)‐[3H] Tomoxetine and (R/S)‐[3H] Nisoxetine Binding in Rat Brain

  1995cited by this paper
• [3H]WIN 35,428 binding to the dopamine uptake carrier. I. Effect of tonicity and buffer composition.

  1994cited by this paper
• 3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters.

  1993cited by this paper
• Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists.

  1993cited by this paper
• [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.

  1992cited by this paper
• Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter

  1991cited by this paper
• [3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.

  1990cited by this paper
• Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.

  1987cited by this paper
• Characterization of Sodium‐Dependent [3H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport Complex

  1986cited by this paper
• Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease

  1985cited by this paper
• Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.

  1985cited by this paper
• Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.

  1984cited by this paper
• [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.

  1984cited by this paper
• Complex Inhibition of [3H]Imipramine Binding by Serotonin and Nontricyclic Serotonin Uptake Blockers

  1983cited by this paper
• Sodium‐Sensitive Cocaine Binding to Rat Striatal Membrane: Possible Relationship to Dopamine Uptake Sites

  1983cited by this paper
• Characterization of [3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes

  1982cited by this paper
• ARYL 1,4-DIALK(EN)YLPIPERAZINES AS SELECTIVE AND VERY POTENT INHIBITORS OF DOPAMINE UPTAKE

  1981cited by this paper
• High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine.

  1980cited by this paper
• Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

  1976cited by this paper

• Mutational effects of the asparagine198 and glutamate223 residues on the human norepinephrine transporter on basal and HIV-1 Tat protein-induced inhibition of dopamine transport.

  2025cites this paper
• Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats

  2022cites this paper
• Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.

  2022cites this paper
• [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein

  2020cites this paper
• Pharmacological profile of methylphenidate-based designer drugs.

  2017cites this paper
• The Role of Cysteines and Histidins of the Norepinephrine Transporter

  2013cites this paper
• The role of central catecholamines in performance during prolonged exercise in warm conditions

  2013cites this paper
• Novel C-1 Substituted Cocaine Analogs Unlike Cocaine or Benztropine

  2012influential citation
• Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.

  2012influential citation
• Site-Directed Mutations near Transmembrane Domain 1 Alter Conformation and Function of Norepinephrine and Dopamine Transporters

  2011cites this paper
• Pharmacological Characterization of a Fluorescent Uptake Assay for the Noradrenaline Transporter

  2007cites this paper
• Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.

  2007cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.

  2006cites this paper
• Studies of the Biogenic Amine Transporters. XI. Identification of a 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) Analog That Allosterically Modulates the Serotonin Transporter

  2005cites this paper
• Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter.

  2004cites this paper